A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal
- PMID: 29422012
- PMCID: PMC5806368
- DOI: 10.1186/s12886-018-0704-7
A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal
Abstract
Background: The recent advancement in the management of chronic renal failure (CRF) has significantly increased the longevity of the patients, which increase the incidence of severe vitreoretinopathy. The vitrectomy is highly risky in this particular group of patients due to their systemic comorbidity. The timing surgical intervention is usually delayed because of the systemic conditions. This study is to evaluate the safety and effectiveness of 25-guage vitrectomy for severe vitreoretinopathy in the CRF patients.
Methods: In this retrospective study, 16 eyes of 16 CRF patients with severe vitreoretinopathy were undergone 25-guage vitrectomy in the department of Ophthalmology of the Second Hospital of Tianjin Medical University from February 2015 to April 2017. The visual outcome, complications and perioperative medical management were documented and analyzed.
Results: The best-corrected visual acuity(BCVA)of fourteen eyes were lower than 20/200 preoperatively. Surgery duration ranged from 28 to 72 min, with a mean of 48.4 ± 13.6 min. During the surgery, 12 eyes were diagnosed with DR, while two them were complicated with tractional retinal detachment and one with branch retinal vein occlusion. Three eyes were diagnosed with branch retinal vein occlusion, and one eye was diagnosed with hypertensive retinopathy. Postoperative BCVA of six eyes ≥20/40, seven eyes ≥20/200, and three eyes < 20/200. BCVA of eight eyes improved more than three lines, three eyes improved two lines, and four eyes improved one line. BCVA decreased from hand movement to light perception in one patient who developed neovascular glaucoma two weeks after surgery.
Conclusion: In chronic renal failure patients with severe vitreoretinopathy, the well-planned minimally invasive vitrectomy is effective and safe. Additionally, careful management of the perioperative systemic conditions is important to improve the visual acuity and quality of life as well.
Keywords: Chronic renal failure; Vitrectomy; Vitreoretinopathy.
Conflict of interest statement
Ethics approval and consent to participate
This study was in agreement with the Declaration of Helsinki and approved by the Ethics Committee at Tianjin Medical University. Informed consent was obtained from each patient.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.Retina. 2012 Feb;32(2):220-5. doi: 10.1097/IAE.0b013e31821c3ec5. Retina. 2012. PMID: 22277905
-
Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.BMC Ophthalmol. 2015 Dec 9;15:173. doi: 10.1186/s12886-015-0167-z. BMC Ophthalmol. 2015. PMID: 26645589 Free PMC article.
-
[Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].Nippon Ganka Gakkai Zasshi. 2006 Dec;110(12):950-60. Nippon Ganka Gakkai Zasshi. 2006. PMID: 17228758 Japanese.
-
Proliferative vitreoretinopathy after trauma.Int Ophthalmol Clin. 2002 Summer;42(3):129-43. doi: 10.1097/00004397-200207000-00015. Int Ophthalmol Clin. 2002. PMID: 12131590 Review. No abstract available.
-
Proliferative Vitreoretinopathy: A Review.Int Ophthalmol Clin. 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258. Int Ophthalmol Clin. 2019. PMID: 30585928 Free PMC article. Review.
Cited by
-
Analysis of factors associated with vision after cataract surgery in chronic renal failure patients on dialysis.BMC Ophthalmol. 2020 Jun 1;20(1):211. doi: 10.1186/s12886-020-01479-w. BMC Ophthalmol. 2020. PMID: 32487044 Free PMC article.
-
Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway.Bioengineered. 2021 Dec;12(1):6538-6558. doi: 10.1080/21655979.2021.1973877. Bioengineered. 2021. PMID: 34528858 Free PMC article.
References
-
- Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, 3rd, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18. Invest Ophthalmol Vis Sci. 1998;39:233–252. - PubMed
-
- Vrabec R, Vatavuk Z, Pavlović D, Sesar A, Cala S, Mandić K, Bućan K. Ocular findings in patients with chronic renal failure undergoing haemodialysis. Coll Antropol. 2005;29(Suppl 1):95–98. - PubMed
-
- Bajracharya L, Shah DN, Raut KB, Koirala S. Ocular evaluation in patients with chronic renal failure--a hospital based study. Nepal Med Coll J. 2008;10(4):209–214. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous